Metropolis Healthcare Ltd reports Q2 FY27 consolidated net profit of ₹754.83 million and declares an interim dividend
- Consolidated revenue was ₹4,968.21 million, up 15.8% year on year and 10.3% sequentially.
- Net profit rose 42.7% year on year and 32.7% sequentially.
- EBITDA margin was approximately 27.0%; limited-review conclusion was unmodified, with no exceptional items reported.
- November 09, 2026, set as the dividend record date.
